![Kate Chevlen](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Kate Chevlen
Corporate Officer/Principal bei
SPYRE THERAPEUTICS, INC.
Profil
Kate Tansey Chevlen currently works at Spyre Therapeutics, Inc., as Chief Commercial Officer from 2026.
Ms. Chevlen also formerly worked at Amgen, Inc., as VP & Global Marketing Head-Immunology.
Ms. Chevlen received her undergraduate degree from Brandeis University and Masters Business Admin degree from Johnson Graduate School of Management.
Aktive Positionen von Kate Chevlen
| Unternehmen | Position | Beginn |
|---|---|---|
| SPYRE THERAPEUTICS, INC. | Corporate Officer/Principal | 12.01.2026 |
Ehemalige bekannte Positionen von Kate Chevlen
| Unternehmen | Position | Ende |
|---|---|---|
| AMGEN INC. | Corporate Officer/Principal | 01.01.2026 |
Ausbildung von Kate Chevlen
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
25
Beziehungen ersten Grades
4
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
| Private Unternehmen | 4 |
|---|---|
Amgen, Inc.
 Amgen, Inc. BiotechnologyHealth Technology Discovers, develops, manufactures and delivers human therapeutics | Health Technology |
Spyre Therapeutics, Inc.
 Spyre Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Operates as a clinical-stage biotechnology company | Health Technology |
Brandeis University
 Brandeis University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Johnson Graduate School of Management
 Johnson Graduate School of Management Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
